Andrew Schiermeier, EVP, Chief Operating Officer at Intellia Therapeutics, Inc. (NTLA), sold 2,754 shares at $55.86 ($154K) on 2021-01-05, disclosed to the SEC on 2021-01-05.
Open-market sale of $154k NTLA by EVP, Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.86 | 1,377 | $77K | 50.0% |
| 2 | $55.86 | 1,377 | $77K | 50.0% |
| Total | $55.86 avg | 2,754 | $154K | 100% |